CRP and chronic kidney disease: Interestingly, in the Spoto et al. study, serum ERFE was associated with clinical outcomes (all-cause mortality and non-fatal CV events) in predialysis CKD and HD patients, independently of confounders like C-reactive protein (CRP) or iron metabolism biomarkers (29).